To see the prevalence of Knee osteoarthritis and to evaluate the effect of Hijamah bila Shart (Dry Cupping) in the cases of Knee osteo-arthritis

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2021
INTERVENTION: Intervention1: Hijamah bila Shart (Dry Cupping): In group A Hijamah bila Shart will be performed in the procedure section of the IBT OPD. The patient will be asked to lie down on procedure table in supine position with their affected knee flexed and then 3 Hijamah cups of equal size will be applied (diameter of cups 5cm, depth 5.5cm and volume 70ml) with the help of suction pump anteriomedially, anteriolaterally and anterio superiorly (above the base of patella) near the articular edge of femur, for 10 minutes. This procedure will be repeated twice a week for 4 weeks. Assessment of safety and efficacy will be done at each follow up till completion of the study, that is on28th day. Control Intervention1: Habbe Suranjan along with Hijamah bila Shart: In group B, besides Hijamah therapy same as in Group A, patient will also be given Habbe Suranjan, 2 tablets twice a day orally for 4 weeks. CONDITION: Health Condition 1: M179‐ Osteoarthritis of knee, unspecified PRIMARY OUTCOME: Visual Analogue Scale (VAS) ; Knee Injury And Osteoarthritis Outcome Score (KOOS) ; Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Index (Modified â?? CRD Pune Version) ; Timepoint: Baseline, 28th day SECONDARY OUTCOME: Prevalence of Knee OA in the total number of patients reporting at the registration counter of the HospitalTimepoint: At the end of three months INCLUSION CRITERIA: â?¢Diagnosed patients of knee OA in age groups of 35 to 65 years. â?¢Subjective pain intensity of 5mmto 74mm (mild to moderate pain) baseline on Visual Analogue Scale (VAS). â?¢Grade 2and grade 3 osteoarthritis in X‐ray film. (Kellgren and Lawrence) â?¢Clinically stable patients. â?¢ESR <40mm/hr â?¢Rheumatoid factors (RF) <1:40 â?¢Patients of all genders. â?¢Patients who are willing to sign the informed consent form and participate in the trial voluntarily.
Epistemonikos ID: 6f719fab9162820341c22d519d8af3497316ca5d
First added on: Mar 24, 2022